As at Nov 21, 2024, the MRK stock has a PE ratio of 20.85. This is based on the current EPS of $4.79 and the stock price of $99.86 per share. A decrease of 91% has been recorded in the PE ratio compared to the average of 242.6 of the last four quarters.
The mean historical PE ratio of Merck over the last ten years is 55.52. The current 20.85 P/E ratio is 62% lower than the historical average. In the past ten years, MRK's PE ratio peaked in the Dec 2023 quarter at 778.71, with a price of $109.02 and an EPS of $0.14. The Sep 2015 quarter marked the lowest point at 13.1, with a price of $49.39 and an EPS of $3.77.
Maximum annual increase: 3,922.26% in 2023
Maximum annual decrease: -58.98% in 2014
Year | PE ratio | Change |
---|---|---|
2023 | 778.71 | 3,922.26% |
2022 | 19.36 | 30.37% |
2021 | 14.85 | -49.35% |
2020 | 29.32 | 23.82% |
2019 | 23.68 | -27.47% |
2018 | 32.65 | -48.94% |
2017 | 63.94 | 54.22% |
2016 | 41.46 | 24.02% |
2015 | 33.43 | 142.6% |
2014 | 13.78 | -58.98% |
The current PE ratio of MRK is lower than the 3, 5 and 10-year averages.
MRK's PE ratio stands lower than its peer stocks LLY and JNJ, but it is higher than NVS's. Merck is presently trading at a lower PE ratio (20.85) than its peer group average of 37.31.
Stock name | PE ratio | Market cap |
---|---|---|
NVS Novartis AG | 12.03 | $207.63B |
MRK Merck & Co Inc | 20.85 | $252.61B |
JNJ Johnson & Johnson | 25.79 | $374.39B |
PFE Pfizer Inc | 33.07 | $142.41B |
ABT Abbott Laboratories | 35.53 | $203.38B |
AMGN Amgen Inc | 36.74 | $155.83B |
LLY ELI LILLY & Co | 80.72 | $711.91B |
BMY Bristol Myers Squibb Co | N/A | $118.1B |
TEVA Teva Pharmaceutical Industries Ltd | N/A | $19.35B |
As of Nov 21, 2024, MRK stock has a price to earnings ratio of 20.85.
The average PE ratio for MRK stock over the past 3 years is 101.63.
The average PE ratio for MRK stock over the past 5 years is 70.91.
Over the last ten years, the quarterly PE ratio reached a historic high of 778.71 in the Dec 2023 quarter.
MRK's current price to earnings ratio is 62% below its 10-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Nov 21, 2024), Merck's stock price is $99.86. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $4.79. Therefore, Merck's PE ratio for today is 20.85. PE RATIO(20.85) = STOCK PRICE($99.86) / TTM EPS($4.79)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.